L01EB07 dacomitinib
ATC group of level 5 – chemical substance · in plain English: targeted cancer medicines (kinase inhibitors)
This site has the patient leaflet or the SPC of 3 medicines in this group.
- 3 prescription only (POM)
Active substance: Dacomitinib – all medicines with this substance, also in combinations.
Place in the ATC classification
- L Antineoplastic and immunomodulating agents 1,791 medicines
- L01 Antineoplastic agents 1,025 medicines
- L01E Protein kinase inhibitors, antineoplastic and immunomodulating agents 353 medicines
- L01EB Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors 40 medicines
- L01EB07 dacomitinib 3 medicines
- L01EB Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors 40 medicines
- L01E Protein kinase inhibitors, antineoplastic and immunomodulating agents 353 medicines
- L01 Antineoplastic agents 1,025 medicines
Medicines
| Medicine | Legal category |
|---|---|
| Vizimpro 15 mg film-coated tablets SPC | Prescription only (POM) |
| Vizimpro 30 mg film-coated tablets SPC | Prescription only (POM) |
| Vizimpro 45 mg film-coated tablets SPC | Prescription only (POM) |
Other groups of the same level
- L01EB01 gefitinib 6 medicines
- L01EB02 erlotinib 25 medicines
- L01EB03 afatinib 4 medicines
- L01EB04 osimertinib 2 medicines
Other names of the ATC group
- German: L01EB07 Dacomitinib
- German: L01EB07 Dacomitinib
- Turkish: L01EB07 dakomitinib
Sources
- Patient leaflets and SPCs: the MHRA product information (products.mhra.gov.uk) and the European Medicines Agency (EMA)
- Active substances, ATC codes and legal categories: the NHS Dictionary of Medicines and Devices (dm+d), NHS Business Services Authority
- World Health Organization (WHO): ATC/DDD classification, group L01EB07
Contains public sector information licensed under the Open Government Licence v3.0.
Ask your doctor or pharmacist which medicine is right for you.